Share Price and Basic Stock Data

Last Updated: November 12, 2024, 11:33 am

Market Cap	38.4 Cr.
Current Price	36.6
High / Low	61.7/27.0
Stock P/E
Book Value	25.9
Dividend Yield	0.00 %
ROCE	2.51 %
ROE	4.72 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Global Longlife Hospital and Research Ltd

Competitors of Global Longlife Hospital and Research Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Global Longlife Hospital and Research Ltd	38.4 Cr.	36.6	61.7/27.0		25.9	0.00 %	2.51 %	4.72 %	10.0
Gian Lifecare Ltd	21.6 Cr.	20.8	29.0/17.0	5.21	19.0	0.00 %	29.2 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	101 Cr.	54.0	108/44.0		15.9	78.7 %	3.29 %	9.12 %	10.0
Family Care Hospitals Ltd	40.5 Cr.	7.50	10.4/6.23	0.98	2.67	0.00 %	15.4 %	24.1 %	10.0
Dr Lalchandani Labs Ltd	7.80 Cr.	18.0	28.9/0.00	9.07	22.4	0.00 %	2.68 %	8.23 %	10.0
Industry Average	27,088.85 Cr	815.13		51.19	89.64	3.80%	11.58%	12.32%	9.00

All Competitor Stocks of Global Longlife Hospital and Research Ltd

Quarterly Result

Month	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024
Sales	19.94	12.87	11.80	11.70	12.33	1.18	0.58
Expenses	13.18	11.61	10.03	9.44	9.62	4.20	4.39
Operating Profit	6.76	1.26	1.77	2.26	2.71	-3.02	-3.81
OPM %	33.90%	9.79%	15.00%	19.32%	21.98%	-255.93%	-656.90%
Other Income	0.07	0.16	0.07	0.17	0.02	0.04	5.69
Interest	0.09	1.31	0.20	0.20	0.41	0.36	0.28
Depreciation	0.58	0.57	0.58	0.59	0.61	0.64	0.48
Profit before tax	6.16	-0.46	1.06	1.64	1.71	-3.98	1.12
Tax %	0.00%	-78.26%	29.25%	35.37%	39.77%	-19.10%	-11.61%
Net Profit	6.17	-0.10	0.76	1.07	1.03	-3.22	1.24
EPS in Rs	8.81	-0.14	0.72	1.02	0.98	-3.07	1.18

Last Updated: November 6, 2024, 6:39 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: September 23, 2024, 2:22 pm

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	33.44	33.32	32.70	32.44	23.38	13.46
Expenses	26.61	29.88	27.26	24.14	19.30	13.68
Operating Profit	6.83	3.44	5.44	8.30	4.08	-0.22
OPM %	20.42%	10.32%	16.64%	25.59%	17.45%	-1.63%
Other Income	0.08	0.03	0.06	0.17	0.24	0.00
Interest	2.07	2.41	2.44	1.62	0.45	0.80
Depreciation	2.15	2.13	1.31	1.14	1.17	1.25
Profit before tax	2.69	-1.07	1.75	5.71	2.70	-2.27
Tax %	49.07%	-18.69%	-16.57%	37.30%	32.59%	-3.52%
Net Profit	1.36	-0.86	2.05	3.57	1.83	-2.19
EPS in Rs	1.94	-1.23	2.93	5.10	1.74	-2.09
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-163.24%	338.37%	74.15%	-48.74%	-219.67%
Change in YoY Net Profit Growth (%)	0.00%	501.61%	-264.23%	-122.89%	-170.93%

Global Longlife Hospital and Research Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2019-2020 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	-17%
3 Years:	-26%
TTM:	-93%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-194%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	-22%

Return on Equity
10 Years:	%
5 Years:	4%
3 Years:	3%
Last Year:	-5%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 3:30 pm

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	7.00	7.00	7.00	7.00	10.50	10.50	10.50
Reserves	5.35	4.49	6.68	9.96	53.79	15.43	16.67
Borrowings	27.18	23.51	17.04	8.69	9.29	12.74	0.00
Other Liabilities	3.77	6.92	6.06	8.33	2.36	3.07	0.20
Total Liabilities	43.30	41.92	36.78	33.98	75.94	41.74	27.37
Fixed Assets	20.17	18.72	17.46	16.71	16.52	17.27	0.00
CWIP	0.00	0.00	0.00	0.00	1.03	0.00	0.00
Investments	0.10	0.10	0.47	0.10	0.10	0.03	18.67
Other Assets	23.03	23.10	18.85	17.17	58.29	24.44	8.70
Total Assets	43.30	41.92	36.78	33.98	75.94	41.74	27.37

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	5.40	3.90	6.88	9.42	-40.42	-5.07
Cash from Investing Activity +	-0.33	-0.04	0.02	0.01	-1.90	-0.82
Cash from Financing Activity +	-4.77	-3.05	-7.22	-9.66	45.70	2.67
Net Cash Flow	0.31	0.81	-0.33	-0.22	3.38	-3.22

Free Cash Flow

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-20.35	-20.07	-11.60	-0.39	-5.21	-12.96

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	94.85	68.68	87.51	100.25	151.43	52.88
Inventory Days	169.49	157.97	34.46	88.98	69.12	131.64
Days Payable	229.91	391.69	138.68	432.74	110.43	765.90
Cash Conversion Cycle	34.44	-165.03	-16.71	-243.52	110.13	-581.38
Working Capital Days	82.85	78.21	57.82	36.34	433.07	14.64
ROCE %		3.81%	12.75%	26.22%	6.35%	-2.51%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%
Public	45.71%	45.70%	45.72%	45.71%	45.71%	45.72%	45.71%	45.71%	45.72%
No. of Shareholders	1,011	948	937	888	889	880	935	947	1,010

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-2.08	1.79	5.11	2.92	-2.02
Diluted EPS (Rs.)	-2.08	1.79	5.11	2.92	-2.02
Cash EPS (Rs.)	-0.89	2.85	6.74	5.61	2.27
Book Value[Excl.RevalReserv]/Share (Rs.)	24.70	61.23	24.23	19.54	13.34
Book Value[Incl.RevalReserv]/Share (Rs.)	24.70	61.23	24.23	19.54	13.34
Revenue From Operations / Share (Rs.)	12.87	22.38	46.88	46.72	47.92
PBDIT / Share (Rs.)	-0.23	4.07	11.79	8.67	5.49
PBIT / Share (Rs.)	-1.43	2.96	10.15	5.98	1.20
PBT / Share (Rs.)	-2.16	2.58	8.16	2.51	-2.24
Net Profit / Share (Rs.)	-2.08	1.74	5.11	2.92	-2.02
PBDIT Margin (%)	-1.83	18.18	25.14	18.56	11.46
PBIT Margin (%)	-11.08	13.22	21.66	12.81	2.51
PBT Margin (%)	-16.76	11.52	17.40	5.37	-4.67
Net Profit Margin (%)	-16.19	7.77	10.89	6.25	-4.21
Return on Networth / Equity (%)	-8.43	2.84	21.06	14.96	-15.15
Return on Capital Employeed (%)	-5.09	4.56	35.19	15.94	3.13
Return On Assets (%)	-5.24	2.40	10.51	5.56	-3.57
Long Term Debt / Equity (X)	0.13	0.05	0.16	0.91	1.87
Total Debt / Equity (X)	0.49	0.14	0.51	0.91	1.87
Asset Turnover Ratio (%)	0.22	0.42	0.92	0.85	0.82
Current Ratio (X)	0.31	4.28	0.82	1.13	1.21
Quick Ratio (X)	0.28	4.17	0.75	1.06	1.04
Inventory Turnover Ratio (X)	11.57	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	-0.32	10.67	5.90	2.50	1.60
Interest Coverage Ratio (Post Tax) (X)	-1.85	5.56	3.55	1.84	0.41
Enterprise Value (Cr.)	53.35	52.71	0.00	0.00	0.00
EV / Net Operating Revenue (X)	3.95	2.24	0.00	0.00	0.00
EV / EBITDA (X)	-215.57	12.33	0.00	0.00	0.00
MarketCap / Net Operating Revenue (X)	3.03	2.00	0.00	0.00	0.00
Price / BV (X)	1.58	0.73	0.00	0.00	0.00
Price / Net Operating Revenue (X)	3.03	2.00	0.00	0.00	0.00
EarningsYield	-0.05	0.03	0.00	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Global Longlife Hospital and Research Ltd as of November 15, 2024 is: 18.70

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 15, 2024, Global Longlife Hospital and Research Ltd is Overvalued by 48.91% compared to the current share price 36.60

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Global Longlife Hospital and Research Ltd as of November 15, 2024 is: 16.52

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 15, 2024, Global Longlife Hospital and Research Ltd is Overvalued by 54.86% compared to the current share price 36.60

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -11.67%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Cash Conversion Cycle of -143.68, which is a positive sign. The company has higher reserves (16.05 cr) compared to borrowings (14.06 cr), indicating strong financial stability. The company has shown consistent growth in sales (28.12 cr) and profit (1.59 cr) over the years.	The stock has a low average ROCE of 7.77%, which may not be favorable. The stock has a high average Working Capital Days of 117.16, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Global Longlife Hospital and Research Ltd:
1. Net Profit Margin: -16.19%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: -5.09% (Industry Average ROCE: 11.58%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: -8.43% (Industry Average ROE: 12.32%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): -1.85
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.28
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 51.19)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.49
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Global Longlife Hospital and Research Ltd. is a Public Limited Listed company incorporated on 20/01/2012 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L85110GJ2012PLC068700 and registration number is 068700. Currently company belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 32.82 Cr. and Equity Capital is Rs. 7.00 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	Global Hospital, Opp. Auda Garden, Ahmedabad Gujarat 380054	investor@globalhospital.co.in http://www.globalhospital.co.in

Management
Name	Position Held
Mr. Sureshkumar Jani	Chairman & Executive Director
Mr. Dhruv Jani	Managing Director
Mrs. Sucheta Jani	Non Executive Director
Mr. Manasvi Thapar	Independent Director
Mr. Sandeep Shah	Independent Director

FAQ

What is the latest intrinsic value of Global Longlife Hospital and Research Ltd?

The latest intrinsic value of Global Longlife Hospital and Research Ltd as on 14 November 2024 is ₹18.70, which is 48.91% lower than the current market price of ₹36.60.

What is the Market Cap of Global Longlife Hospital and Research Ltd?

The Market Cap of Global Longlife Hospital and Research Ltd is 38.4 Cr..

What is the current Stock Price of Global Longlife Hospital and Research Ltd as on 14 November 2024?

The current stock price of Global Longlife Hospital and Research Ltd as on 14 November 2024 is ₹36.6.

What is the High / Low of Global Longlife Hospital and Research Ltd stocks in FY 2024?

In FY 2024, the High / Low of Global Longlife Hospital and Research Ltd stocks is 61.7/27.0.

What is the Stock P/E of Global Longlife Hospital and Research Ltd?

The Stock P/E of Global Longlife Hospital and Research Ltd is .

What is the Book Value of Global Longlife Hospital and Research Ltd?

The Book Value of Global Longlife Hospital and Research Ltd is 25.9.

What is the Dividend Yield of Global Longlife Hospital and Research Ltd?

The Dividend Yield of Global Longlife Hospital and Research Ltd is 0.00 %.

What is the ROCE of Global Longlife Hospital and Research Ltd?

The ROCE of Global Longlife Hospital and Research Ltd is 2.51 %.

What is the ROE of Global Longlife Hospital and Research Ltd?

The ROE of Global Longlife Hospital and Research Ltd is 4.72 %.

What is the Face Value of Global Longlife Hospital and Research Ltd?

The Face Value of Global Longlife Hospital and Research Ltd is 10.0.